NIOX Group (LON:NIOX) Releases Earnings Results

NIOX Group (LON:NIOXGet Free Report) released its quarterly earnings data on Tuesday. The company reported GBX 2.27 ($0.03) earnings per share (EPS) for the quarter, Digital Look Earnings reports. NIOX Group had a net margin of 28.21% and a return on equity of 13.29%.

NIOX Group Stock Performance

Shares of NIOX Group stock opened at GBX 74.60 ($0.97) on Thursday. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.31 and a quick ratio of 1.94. The stock has a market capitalization of £30.64 billion, a price-to-earnings ratio of 3,078.61 and a beta of 0.92. The business has a 50-day moving average of GBX 64.30 and a 200 day moving average of GBX 63.95. NIOX Group has a 12 month low of GBX 57 ($0.74) and a 12 month high of GBX 80 ($1.04).

Insider Buying and Selling at NIOX Group

In other news, insider Jonathan Emms acquired 127,454 shares of the stock in a transaction that occurred on Tuesday, April 1st. The shares were purchased at an average cost of GBX 8 ($0.10) per share, for a total transaction of £10,196.32 ($13,240.25). 46.72% of the stock is owned by corporate insiders.

NIOX Group Company Profile

(Get Free Report)

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.

See Also

Receive News & Ratings for NIOX Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NIOX Group and related companies with MarketBeat.com's FREE daily email newsletter.